Women’s Health News

DENVER — For women with polycystic ovary syndrome, therapeutic lifestyle modifications help to regulate menstruation, improve glucose metabolism and increase fertility, according to a speaker at the Lifestyle Medicine Conference.

HPV detectability was associated with better clinical cervical cancer prognosis vs. no detectable virus with up to a 41% lower mortality risk, according to a systematic review and meta-analysis published in Obstetrics & Gynecology.

Researchers completed the first ever human challenge trial for Zika virus, deliberately infecting volunteers to identify strains of the virus that can be safely used to test vaccines against the mosquito-borne pathogen.

Fewer than half of hospitals participating in a maternity care quality collaborative reported systematic screening for social determinants of health in pregnancy, researchers reported in the American Journal of Obstetrics and Gynecology.

At 2 years, women who had received relugolix combination therapy for 52 weeks and then withdrew therapy continued to have less menstrual blood loss and pain caused by uterine fibroids, researchers reported.

Black and Hispanic women with early stage breast cancer in certain subgroups had worse survival rates compared with women of other races and ethnicities, according to results of a cohort study published in JAMA Network Open.

Following the Dobbs v. Jackson Women's Health Organization decision, rates of vasectomy and tubal sterilization rose, according to data presented at the American Society for Reproductive Medicine Scientific Congress & Expo.

The overall incidence rate of abortions reimbursed through commercial insurance decreased 14% during the early stage of the COVID-19 pandemic despite eased regulations, and it did not return to pre-pandemic levels, a recent study found.

NEW ORLEANS — Both new-onset and ongoing untreated hypertension were associated with increased risks for newly diagnosed uterine fibroids among midlife women, according to findings presented at the ASRM Scientific Congress & Expo.

Obesity was linked to an increased breast cancer recurrence risk among postmenopausal women with hormone receptor-positive early-stage breast cancer who were treated with aromatase inhibitors, researchers reported in JAMA Network Open.